Aref Al-Kali, M.D., is a hematologist and Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, specializing in myeloid and other complex blood disorders, including acute myeloid leukemia, myelodysplastic syndromes, chronic myelomonocytic leukemia, myeloproliferative neoplasms, large granular lymphocyte disorders, and acute lymphoblastic leukemia. His clinical and research interests focus on novel therapies, molecular and cytogenetic abnormalities, and advancing treatment for hematologic malignancies. Dr. Al-Kali is committed to evidence-based, patient-centered care and is actively involved in medical education, research, and professional leadership within hematology.